🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.560
-0.270 (-5.59%)
At close: Nov 20, 2026, 4:00 PM EST
4.749
+0.189 (4.15%)
After-hours: Nov 20, 2026, 7:30 PM EST

Strata Critical Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
280.76197.14146.82225.18146.1267.16
Revenue Growth
68.38%34.28%-34.80%54.11%117.58%32.92%
Cost of Revenue
220.19156.02117.23183.06123.8554.31
Gross Profit
60.5641.1329.5942.1222.2812.85
Selling, General & Admin
58.5851.1349.4482.1867.2342.96
Research & Development
---4.635.552.16
Amortization of Goodwill & Intangibles
15.12.61.26---
Operating Expenses
73.6853.7450.786.872.7745.11
Operating Income
-13.12-12.61-21.11-44.68-50.5-32.26
Interest & Investment Income
1.594.247.218.443.430.74
Other Non Operating Income (Expenses)
2.954.28-0.852.1324.23-9.15
EBT Excluding Unusual Items
-8.58-4.09-14.74-34.11-22.84-40.67
Merger & Restructuring Charges
-3.38-2.05-0.04--3.03-
Gain (Loss) on Sale of Investments
-1.28-5.2-0.01-2.16-
Asset Writedown
-7.43-2.71--20.75--
Legal Settlements
-0.45-6.02-1.38---
Other Unusual Items
----2.68--
Pretax Income
-21.12-20.07-16.16-57.54-28.03-40.67
Income Tax Expense
----1.47-0.77-3.75
Earnings From Continuing Operations
-21.12-20.07-16.16-56.08-27.26-36.92
Earnings From Discontinued Operations
-3.6961.41-11.15---
Net Income
-24.8141.35-27.31-56.08-27.26-36.92
Preferred Dividends & Other Adjustments
-----0.02
Net Income to Common
-24.8141.35-27.31-56.08-27.26-36.94
Net Income Growth
------
Shares Outstanding (Basic)
868277747154
Shares Outstanding (Diluted)
868277747154
Shares Change
6.93%5.93%5.41%3.21%31.65%26.18%
EPS (Basic)
-0.290.50-0.35-0.76-0.38-0.68
EPS (Diluted)
-0.290.50-0.35-0.76-0.38-0.68
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0.81-58.51-33.38-34.46-37.86-22.12
Free Cash Flow Per Share
0.01-0.71-0.43-0.47-0.53-0.41
Gross Margin
21.57%20.86%20.15%18.71%15.24%19.14%
Operating Margin
-4.67%-6.40%-14.38%-19.84%-34.56%-48.04%
Profit Margin
-8.84%20.97%-18.60%-24.90%-18.66%-55.00%
Free Cash Flow Margin
0.29%-29.68%-22.74%-15.30%-25.91%-32.93%
EBITDA
8.78-5.71-17.85-37.57-44.77-31.09
EBITDA Margin
3.13%-2.90%-12.16%-16.68%-30.64%-46.29%
D&A For EBITDA
21.96.93.267.115.731.17
EBIT
-13.12-12.61-21.11-44.68-50.5-32.26
EBIT Margin
-4.67%-6.40%-14.38%-19.84%-34.56%-48.04%
Advertising Expenses
---4.064.54-
SEC Filings: 10-K · 10-Q